# CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

> **NCT03217331** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cardiora Pty. Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Right Heart Failure
- Left Ventricular Assist Device

## Interventions

- **DRUG:** CRD-102

## Key facts

- **NCT ID:** NCT03217331
- **Lead sponsor:** Cardiora Pty. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2018-10-10
- **Final completion:** 2019-05-30
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217331, "CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03217331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*